Read More Pharma Industry News AbbVie and Genmab’s TEPKINLY approved by EC for advanced lymphoma AbbVie (NYSE: ABBV) and Genmab (NASDAQ: GMAB) have announced that the European Commission (EC) has granted conditional marketing… byPallavi MadhirajuAugust 20, 2024